ID

44494

Description

A Phase I/II Study of HE3235 in Patients With Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00716794

Link

https://clinicaltrials.gov/show/NCT00716794

Keywords

Versions (2)
  1. 9/8/18 9/8/18 -
  2. 9/27/21 9/27/21 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

September 27, 2021

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Prostate Cancer NCT00716794

English

Eligibility Prostate Cancer NCT00716794

1 forms  
Criteria
Description

Criteria

patient is male and at least 18 years of age, at the time of screening;
Description

Gender | Age

Data type

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
patient has metastatic disease (any t, any n, m1);
Description

Neoplasm Metastasis TNM clinical staging

Data type

boolean

Alias
UMLS CUI [1,1]
C0027627
UMLS CUI [1,2]
C3258246
patient has failed at least 1 taxane regimen; or patient has symptomatic or asymptomatic crpc and is chemotherapy-naïve
Description

Taxane Regimen Quantity failed | CRPC Symptomatic | CRPC Asymptomatic | Chemotherapy naive

Data type

boolean

Alias
UMLS CUI [1,1]
C0215136
UMLS CUI [1,2]
C0040808
UMLS CUI [1,3]
C1265611
UMLS CUI [1,4]
C0231175
UMLS CUI [2,1]
C1328504
UMLS CUI [2,2]
C0231220
UMLS CUI [3,1]
C1328504
UMLS CUI [3,2]
C0231221
UMLS CUI [4,1]
C0392920
UMLS CUI [4,2]
C0919936
patient has histologically or cytologically confirmed adenocarcinoma of the prostate;
Description

Adenocarcinoma of prostate

Data type

boolean

Alias
UMLS CUI [1]
C0007112
patient has progression of disease despite adequate hormone therapy, demonstrated by one of the following:
Description

Disease Progression | Hormone Therapy

Data type

boolean

Alias
UMLS CUI [1]
C0242656
UMLS CUI [2]
C0279025
psa level of at least 2 ng/ml that has risen on at least 2 successive occasions, at least 1 week apart.
Description

Prostate specific antigen measurement | Raised prostate specific antigen Quantity

Data type

boolean

Alias
UMLS CUI [1]
C0201544
UMLS CUI [2,1]
C0178415
UMLS CUI [2,2]
C1265611
evaluable disease progression by modified recist (response evaluation criteria in solid tumors) criteria;
Description

Evaluable Disease Progression

Data type

boolean

Alias
UMLS CUI [1,1]
C1516986
UMLS CUI [1,2]
C0242656
progression of metastatic bone disease on bone scan with > 2 new lesions
Description

Secondary malignant neoplasm of bone Progression Bone scan | Lesion New Quantity Bone scan

Data type

boolean

Alias
UMLS CUI [1,1]
C0153690
UMLS CUI [1,2]
C0449258
UMLS CUI [1,3]
C0203668
UMLS CUI [2,1]
C0221198
UMLS CUI [2,2]
C0205314
UMLS CUI [2,3]
C1265611
UMLS CUI [2,4]
C0203668
patient has ecog (eastern cooperative oncology group) performance status of 0-2;
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
main exclusion criteria:
Description

Exclusion Criteria Main

Data type

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C1542147
patient has symptomatic parenchymal brain metastases or active epidural disease requiring whole-brain irradiation treated epidural disease is allowed
Description

Metastatic malignant neoplasm to brain Parenchymal Symptomatic | Epidural space Disease Requirement Whole brain radiation therapy | Epidural space Disease Treated allowed

Data type

boolean

Alias
UMLS CUI [1,1]
C0220650
UMLS CUI [1,2]
C4277702
UMLS CUI [1,3]
C0231220
UMLS CUI [2,1]
C0228134
UMLS CUI [2,2]
C0012634
UMLS CUI [2,3]
C1514873
UMLS CUI [2,4]
C1520143
UMLS CUI [3,1]
C0228134
UMLS CUI [3,2]
C0012634
UMLS CUI [3,3]
C1522326
UMLS CUI [3,4]
C0683607
patient has active infection;
Description

Communicable Disease

Data type

boolean

Alias
UMLS CUI [1]
C0009450
patient having a history of clinically significant cardiovascular disease (such as chf), clinically significant hepatic, respiratory or renal abnormalities;
Description

Cardiovascular Disease | Congestive heart failure | Liver Dysfunction | Respiratory abnormality | Abnormal renal function

Data type

boolean

Alias
UMLS CUI [1]
C0007222
UMLS CUI [2]
C0018802
UMLS CUI [3]
C0086565
UMLS CUI [4]
C4018871
UMLS CUI [5]
C0151746
patient who has any clinically significant abnormalities in laboratory results at screening
Description

Laboratory test result abnormal

Data type

boolean

Alias
UMLS CUI [1]
C0438215
patient who has a history of clinically significant neurological or psychiatric condition;
Description

Nervous system disorder | Mental condition Clinical Significance

Data type

boolean

Alias
UMLS CUI [1]
C0027765
UMLS CUI [2,1]
C3840291
UMLS CUI [2,2]
C2826293
additional criteria are applicable to expansion cohorts.
Description

Criteria Additional | Cohort Expanded

Data type

boolean

Alias
UMLS CUI [1,1]
C0243161
UMLS CUI [1,2]
C1524062
UMLS CUI [2,1]
C0599755
UMLS CUI [2,2]
C0205229
Back to the top of the page

Similar models

Eligibility Prostate Cancer NCT00716794

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Gender | Age
Item
patient is male and at least 18 years of age, at the time of screening;
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Neoplasm Metastasis TNM clinical staging
Item
patient has metastatic disease (any t, any n, m1);
boolean
C0027627 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
Taxane Regimen Quantity failed | CRPC Symptomatic | CRPC Asymptomatic | Chemotherapy naive
Item
patient has failed at least 1 taxane regimen; or patient has symptomatic or asymptomatic crpc and is chemotherapy-naïve
boolean
C0215136 (UMLS CUI [1,1])
C0040808 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C0231175 (UMLS CUI [1,4])
C1328504 (UMLS CUI [2,1])
C0231220 (UMLS CUI [2,2])
C1328504 (UMLS CUI [3,1])
C0231221 (UMLS CUI [3,2])
C0392920 (UMLS CUI [4,1])
C0919936 (UMLS CUI [4,2])
Adenocarcinoma of prostate
Item
patient has histologically or cytologically confirmed adenocarcinoma of the prostate;
boolean
C0007112 (UMLS CUI [1])
Disease Progression | Hormone Therapy
Item
patient has progression of disease despite adequate hormone therapy, demonstrated by one of the following:
boolean
C0242656 (UMLS CUI [1])
C0279025 (UMLS CUI [2])
Prostate specific antigen measurement | Raised prostate specific antigen Quantity
Item
psa level of at least 2 ng/ml that has risen on at least 2 successive occasions, at least 1 week apart.
boolean
C0201544 (UMLS CUI [1])
C0178415 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
Evaluable Disease Progression
Item
evaluable disease progression by modified recist (response evaluation criteria in solid tumors) criteria;
boolean
C1516986 (UMLS CUI [1,1])
C0242656 (UMLS CUI [1,2])
Secondary malignant neoplasm of bone Progression Bone scan | Lesion New Quantity Bone scan
Item
progression of metastatic bone disease on bone scan with > 2 new lesions
boolean
C0153690 (UMLS CUI [1,1])
C0449258 (UMLS CUI [1,2])
C0203668 (UMLS CUI [1,3])
C0221198 (UMLS CUI [2,1])
C0205314 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
C0203668 (UMLS CUI [2,4])
ECOG performance status
Item
patient has ecog (eastern cooperative oncology group) performance status of 0-2;
boolean
C1520224 (UMLS CUI [1])
Exclusion Criteria Main
Item
main exclusion criteria:
boolean
C0680251 (UMLS CUI [1,1])
C1542147 (UMLS CUI [1,2])
Metastatic malignant neoplasm to brain Parenchymal Symptomatic | Epidural space Disease Requirement Whole brain radiation therapy | Epidural space Disease Treated allowed
Item
patient has symptomatic parenchymal brain metastases or active epidural disease requiring whole-brain irradiation treated epidural disease is allowed
boolean
C0220650 (UMLS CUI [1,1])
C4277702 (UMLS CUI [1,2])
C0231220 (UMLS CUI [1,3])
C0228134 (UMLS CUI [2,1])
C0012634 (UMLS CUI [2,2])
C1514873 (UMLS CUI [2,3])
C1520143 (UMLS CUI [2,4])
C0228134 (UMLS CUI [3,1])
C0012634 (UMLS CUI [3,2])
C1522326 (UMLS CUI [3,3])
C0683607 (UMLS CUI [3,4])
Communicable Disease
Item
patient has active infection;
boolean
C0009450 (UMLS CUI [1])
Cardiovascular Disease | Congestive heart failure | Liver Dysfunction | Respiratory abnormality | Abnormal renal function
Item
patient having a history of clinically significant cardiovascular disease (such as chf), clinically significant hepatic, respiratory or renal abnormalities;
boolean
C0007222 (UMLS CUI [1])
C0018802 (UMLS CUI [2])
C0086565 (UMLS CUI [3])
C4018871 (UMLS CUI [4])
C0151746 (UMLS CUI [5])
Laboratory test result abnormal
Item
patient who has any clinically significant abnormalities in laboratory results at screening
boolean
C0438215 (UMLS CUI [1])
Nervous system disorder | Mental condition Clinical Significance
Item
patient who has a history of clinically significant neurological or psychiatric condition;
boolean
C0027765 (UMLS CUI [1])
C3840291 (UMLS CUI [2,1])
C2826293 (UMLS CUI [2,2])
Criteria Additional | Cohort Expanded
Item
additional criteria are applicable to expansion cohorts.
boolean
C0243161 (UMLS CUI [1,1])
C1524062 (UMLS CUI [1,2])
C0599755 (UMLS CUI [2,1])
C0205229 (UMLS CUI [2,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial